Which category describes visually complex hallucinations that are associated with late-stage Alzheimer's disease, early Lewy body disease, or medications used to treat Parkinson's disease?

• A. Seizure-induced visual hallucinations
• B. Migraine aura visual hallucinations
• C. Narcolepsy visual hallucinations
• D. Neurodegenerative visual hallucinations

Answer: (D)

These are neurodegenerative visual hallucinations—formed, detailed images that arise from progressive brain disease or the medications used to treat it. In late-stage Alzheimer's, the brain undergoes widespread neurodegenerative changes, which can produce complex visual experiences. Early Lewy body disease characteristically features well-formed visual hallucinations, often involving people or animals, as a key clinical sign. Parkinson’s disease itself and its treatments (like dopaminergic medications) can provoke vivid, sometimes colorful, visual hallucinations, especially as the disease progresses or with medication adjustments.

In contrast, seizure-induced visual experiences are typically tied to epileptic activity and can be brief or aura-like, not classically linked to neurodegenerative progression. Migraine aura usually presents as simple geometric shapes, flickering lights, or zigzag lines rather than detailed, scene-like images. Narcolepsy hallucinations tend to occur at sleep-wake transitions (hypnagogic or hypnopompic) and aren’t the same pattern seen with late-stage Alzheimer’s or Lewy body disease.